Luc Ferrari

Prof. Luc Ferrari

Institut Jean Lamour, UMR 7198, CNRS, Université de Lorraine, Nancy, France
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1992 in Biochemical Pharmacology
Verified
Journal Article
Closed access
YCY.L. Chen
Y.L. Chen
IFI. Florentin
I. Florentin
ABA.M. Batt
A.M. Batt
Luc FerrariLuc Ferrari
Luc Ferrari
JGJ.P. Giroud
J.P. Giroud
LCL. Chauvelot-Moachon
L. Chauvelot-Moachon

1 September 1999 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
TBThomas B. Barclay
Thomas B. Barclay
JPJeffrey M. Peters
Jeffrey M. Peters
MSMarion B. Sewer
Marion B. Sewer
Luc FerrariLuc Ferrari
Luc Ferrari
FGFrank J. Gonzalez
Frank J. Gonzalez
EMEdward T. Morgan
Edward T. Morgan

1 June 2019 in Toxicology Letters
Verified
Journal Article
Open access
RSRamia Safar
Ramia Safar
ZDZahra Doumandji
Zahra Doumandji
TSTimeh Saidou
Timeh Saidou
Luc FerrariLuc Ferrari
Luc Ferrari
SNSara Nahle
Sara Nahle
OJOlivier Joubert
Olivier Joubert
Despite a wide production and use of zinc oxide nanoparticles (ZnONP), their toxicological study is only of limited number and their impact at a molecular level is seldom addressed. Thus, we have used, as a model, zinc oxide nanoparticle NM110 (ZnO110NP) exposure to PMA-differentiated THP-1 macrophages. The cell viability was studied at the cellular level using WST-1, LDH and Alamar Blue® assays, as well as at the molecular level by transcriptomic analysis. Exposure of cells to ZnO110NP for 24 h decreased their viability in a dose-dependent manner with mean inhibitory concentrations (IC50) of 8.1 μg/mL. Transcriptomic study of cells exposed to two concentrations of ZnO110NP: IC50 and a quarter of it (IC50/4) for 4 h showed that the expressions of genes involved in metal metabolism are perturbed. In addition, expression of genes acting in transcription regulation and DNA binding, as well as clusters of genes related to protein synthesis and structure were altered. It has to be noted that the expressions of metallothioneins genes (MT1, MT2) and genes of heat-shock proteins genes (HSP) were strongly upregulated for both conditions. These genes might be used as an early marker of exposure to ZnONP. On the contrary, at IC50 exposure, modifications of gene expression involved in inflammation, apoptosis and mitochondrial suffering were noted indicating a less specific cellular response. Overall, this study brings a resource of transcriptional data for ZnONP toxicity for further mechanistic studies.

1 July 2001 in Molecular Pharmacology
Verified
Journal Article
Closed access
Luc FerrariLuc Ferrari
Luc Ferrari
NPNing Peng
Ning Peng
JHJames R. Halpert
James R. Halpert
EMEdward T. Morgan
Edward T. Morgan
There are conflicting reports about the role of nitric oxide in the down-regulation of cytochrome P450 that occurs when animals or cultured hepatocytes are exposed to inflammatory stimuli. Here, we investigated the participation of NO in the down-regulation of CYP2B1 by bacterial endotoxin (LPS) in rat hepatocytes cultured on Matrigel. LPS caused the down-regulation of CYP2B1 mRNA to 20% of control values within 12 h of treatment, and this was not reversed by concentrations of NO synthase inhibitors that completely blocked NO production. LPS was several orders of magnitude more potent in the down-regulation of CYP2B1 mRNA than in induction of NO production. In contrast, concentrations of LPS in the 1 to 100 ng/ml range induced NO production and produced a rapid down-regulation of CYP2B1 protein to 30% and <5% of control at 6 and 24 h, respectively, that could be completely prevented both by inhibitors of NO synthase and by LY83583, which prevents NO synthase-2 induction. The blockade of CYP2B1 down-regulation by NO synthase inhibitors was reversed by arginine, and the NO donors S-nitrosoglutathione andS-nitroso-N-acetylpenicillamine mimicked CYP2B1 protein suppression. Taken together, these experiments demonstrate two independent mechanisms of CYP2B1 down-regulation by LPS: a rapid, NO-dependent suppression of the protein occurring at high concentrations of LPS and a slower, NO-independent pretranslational suppression occurring at low concentrations of LPS.

3 January 2019 in Journal of Applied Toxicology
Verified
Journal Article
Open access
PDF file
SNSara Nahle
Sara Nahle
RSRamia Safar
Ramia Safar
SGStéphanie Grandemange
Stéphanie Grandemange
BFBernard Foliguet
Bernard Foliguet
MLMélanie Leroux
Mélanie Leroux
Luc FerrariLuc Ferrari
Luc Ferrari
Human exposure to airborne carbon nanotubes (CNT) is increasing because of their applications in different sectors; therefore, they constitute a biological hazard. Consequently, developing studies on CNT toxicity become a necessity. CNTs can have different properties in term of length, size and charge. Here, we compared the cellular effect of multiwall (MWCNTs) and single wall CNTs (SWCNTs). MWCNTs consist of multiple layers of graphene, while SWCNTs are monolayers. The effects of MWCNTs and SWCNTs were evaluated by the water‐soluble tetrazolium salt cell proliferation assay on NR8383 cells, rat alveolar macrophage cell line (NR8383). After 24 hours of exposure, MWCNTs showed higher toxicity (50% inhibitory concentration [IC50] = 3.2 cm2/cm2) than SWCNTs (IC50 = 44 cm2/cm2). Only SWCNTs have induced NR8383 cells apoptosis as assayed by flow cytometry using the annexin V/IP staining test. The expression of genes involved in oxidative burst (Ncf1), inflammation (Nfκb, Tnf‐α, Il‐6 and Il‐1β), mitochondrial damage (Opa) and apoptotic balance (Pdcd4, Bcl‐2 and Casp‐8) was determined. We found that MWCNT exposure predominantly induce inflammation, while SWCNTs induce apoptosis and impaired mitochondrial function. Our results clearly suggest that MWCNTs are ideal candidates for acute inflammation induction. In vivo studies are required to confirm this hypothesis. However, we conclude that toxicity of CNTs is dependent on their physical and chemical characteristics.

17 April 2007 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
PDF file
YGYann GUEGUEN
Yann GUEGUEN
Luc FerrariLuc Ferrari
Luc Ferrari
MSMaâmar Souidi
Maâmar Souidi
ABAnne‐Marie Batt
Anne‐Marie Batt
CLClaude Lutton
Claude Lutton
SSSofia SIEST
Sofia SIEST